Linear 1 3-diarylpropanoids

Organic compounds contain a central propyl group (3 carbon chain) with one phenyl group bonded to the first and the third carbons in the propyl chain; the propyl chain may contain other functional groups, such as a carbon - carbon double bond.

Search Within Results

601 – 615 of 719 results

601

AARON CHEMICALS LLC SODIUM 8 2 HYDROXYBENZOYL 100G

sodium 8-[(2-hydroxybenzoyl)amino]octanoate, 100g

Pricing & Availability

602

Chemscene CHEMSCENE

5000576599 1-3 5-DIFLUORO-2-HYDROXYPHE 1G

Pricing & Availability

603

Apexbio Technology LLC 4-METHOXYCHALCONE 1-10000mg

4-Methoxychalcone-1 (CAS No 959-33-1) is a flavonoid derivative often studied in the field of biomedical research It originates from the chalcone family known for diverse biological activities Its mechanism of action involves the modulation of key signaling pathways potentially affecting inflammatory and oxidative stress responses In vitro it exhibits biological activity in the nanomolar to low micromolar range showcasing its potency Common applications include studies using various cancer cell lines where it is tested for antiproliferative effects It is also utilized in animal models to explore its therapeutic potential in disease contexts In drug screening it serves as a candidate for evaluating new therapeutic strategies due to its bioactive properties Experimental concentrations typically depend on the specific research design allowing for flexibility in application across different experimental setups ensuring adaptability to varied research objectives

Pricing & Availability

604

Medchemexpress LLC Brepocitinib P-Tosylate | 2140301-96-6 | 99.99% | 561.60 | 1 MG

Brepocitinib P-Tosylate is a potent dual Janus kinase 1 (JAK1) and TYK2 inhibitor. It also inhibits JAK2 and JAK3. This compound is intended for research use only.

Potently inhibits TYK2/JAK2 mediated IL-12/pSTAT4 and IL-23/pSTAT3.
Shows good potency against IL6/pStat1 in CD3+ cellular subset.
Inhibits JAK1/JAK3 driven γ-common chain cytokines like IL-15/pStat5 and IL-21/pSTAT3.
Inhibits EPO/pSTAT5 (JAK2 homodimer).
Inhibits IL10/pSTAT3 (TYK2/JAK1) and IL27/pSTAT3 (JAK1/JAK2/TYK2).
Significantly reduces paw volume increase in animal models of arthritis.
Involved in clinical trials for various inflammatory and autoimmune conditions.